New Sleeping Sickness Drug Gets Green Light

Fexinidazole is a new drug for the treatment of Human African Trypanosomiasis commonly known as sleeping sickness. It is the first all-oral treatment for the disease which is transmitted by the bite of a tsetse fly, and has been approved by the European Medicines Agency.

  • East Africa:   And Now, a New Drug for Sleeping Sickness

    East African, 28 November 2018

    Scientists working on Neglected Tropical Diseases have welcomed the approval of a new drug for the treatment of Human African Trypanosomiasis, commonly known as sleeping sickness. Read more »

Tsetse fly (file photo).

Don't Miss

AllAfrica publishes around 900 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.